Overview of the different isolation and marker strategies, used in MM studies
Vesicle type . | Isolation method . | Protocol . | Size† . | Markers . | Reference . |
---|---|---|---|---|---|
exo | Isolation kits, ∗∗∗also used UC | Exoquick | ≤150 nm | CD63, CD81,+Alix∗ or +Tsg101∗∗ | 22,26,46,49,45∗,51,54∗∗,63∗∗∗ |
CD63, CD81, Tsg101, syntenin | 34 | ||||
Hsp70, flotilin 1 | 60 | ||||
Hsp70, CD63, CD9,+Alix∗ or +LAMP2∗∗ calreticulin negative | 56,67∗,61∗∗ | ||||
HspP70/90, Alix, Tsg101, flotilin 1, calreticulin negative | 23 | ||||
Hsp70/90, flotilin 1, CD63,+Alix∗ calreticulin negative | 42,52,65∗ | ||||
CD63, CD9, flotilin 1, calreticulin negative | 77 | ||||
ExoEasy kit | ≤150 nm | Tsg101 | 59 | ||
? | CD63, CD81 | 57,58 | |||
Total exosome isolation kit | ≤150 nm | CD63, Hsp70 | 50 | ||
Differential centrifugation | 1 | ≤100 nm | LAMP1, Alix, galectin negative | 78 | |
2 | ≤100 nm | Alix, CD63, calnexin negative no explicit markers∗ | 31,32,35∗,36∗ | ||
3 | 100 nm | Hsp70, CD63, Tsg101 | 25 | ||
4 | ≤150 nm | Rab5, LAMP2, CD63, GM130 negative | 80 | ||
5 | ≤150 nm | Hsp70, Tsg101, CD81, CD63, calreticulin negative, no markers∗ only Hsp70∗∗ | 44∗,47∗∗,48 | ||
∗Also used exoquick for patient material | CD63, flotilin 1, clathrin only CD63∗ | 62,72,73∗ | |||
6 | 150 nm | Tsg101, Alix, GM130, and α-tubulin negative | 33 | ||
∗Also used different kits for patient material | 7 | ≤150 nm | Tsg101, CD81 | 68∗ | |
8 | ≤200 nm | CD63, no markers∗ | 27,66∗,69 | ||
9 | 50-350 nm | Alix, CD9, LAMP1 | 40 | ||
UC | 100 000g, 1 h | ≤100 nm | CD63, Hsp70 | 37 | |
120 000g, 2 h | 150 nm | CD63, Alix, Tsg101, Rab5 | 53 | ||
MV | Centrifugation | 13 000g | ≤200 nm | No markers | 24 |
16 000g | ? | No markers | 28 | ||
10 | 99% 100 nm, 1%> 300 nm | No markers | 29 | ||
11 | 100 nm to 1μm | Alix, Tsg101, CD63, CD9 | 39 | ||
12 | ≤200 nm | No markers | 68 | ||
ApoEV | 13 | 150 nm | CD63, CD9, flotilin 1, Alix, syntenin, annexin | 79 | |
MV or exo? | Concentration via centrifugal filters | 150 nm | Alix, CD81 | 76 |
Vesicle type . | Isolation method . | Protocol . | Size† . | Markers . | Reference . |
---|---|---|---|---|---|
exo | Isolation kits, ∗∗∗also used UC | Exoquick | ≤150 nm | CD63, CD81,+Alix∗ or +Tsg101∗∗ | 22,26,46,49,45∗,51,54∗∗,63∗∗∗ |
CD63, CD81, Tsg101, syntenin | 34 | ||||
Hsp70, flotilin 1 | 60 | ||||
Hsp70, CD63, CD9,+Alix∗ or +LAMP2∗∗ calreticulin negative | 56,67∗,61∗∗ | ||||
HspP70/90, Alix, Tsg101, flotilin 1, calreticulin negative | 23 | ||||
Hsp70/90, flotilin 1, CD63,+Alix∗ calreticulin negative | 42,52,65∗ | ||||
CD63, CD9, flotilin 1, calreticulin negative | 77 | ||||
ExoEasy kit | ≤150 nm | Tsg101 | 59 | ||
? | CD63, CD81 | 57,58 | |||
Total exosome isolation kit | ≤150 nm | CD63, Hsp70 | 50 | ||
Differential centrifugation | 1 | ≤100 nm | LAMP1, Alix, galectin negative | 78 | |
2 | ≤100 nm | Alix, CD63, calnexin negative no explicit markers∗ | 31,32,35∗,36∗ | ||
3 | 100 nm | Hsp70, CD63, Tsg101 | 25 | ||
4 | ≤150 nm | Rab5, LAMP2, CD63, GM130 negative | 80 | ||
5 | ≤150 nm | Hsp70, Tsg101, CD81, CD63, calreticulin negative, no markers∗ only Hsp70∗∗ | 44∗,47∗∗,48 | ||
∗Also used exoquick for patient material | CD63, flotilin 1, clathrin only CD63∗ | 62,72,73∗ | |||
6 | 150 nm | Tsg101, Alix, GM130, and α-tubulin negative | 33 | ||
∗Also used different kits for patient material | 7 | ≤150 nm | Tsg101, CD81 | 68∗ | |
8 | ≤200 nm | CD63, no markers∗ | 27,66∗,69 | ||
9 | 50-350 nm | Alix, CD9, LAMP1 | 40 | ||
UC | 100 000g, 1 h | ≤100 nm | CD63, Hsp70 | 37 | |
120 000g, 2 h | 150 nm | CD63, Alix, Tsg101, Rab5 | 53 | ||
MV | Centrifugation | 13 000g | ≤200 nm | No markers | 24 |
16 000g | ? | No markers | 28 | ||
10 | 99% 100 nm, 1%> 300 nm | No markers | 29 | ||
11 | 100 nm to 1μm | Alix, Tsg101, CD63, CD9 | 39 | ||
12 | ≤200 nm | No markers | 68 | ||
ApoEV | 13 | 150 nm | CD63, CD9, flotilin 1, Alix, syntenin, annexin | 79 | |
MV or exo? | Concentration via centrifugal filters | 150 nm | Alix, CD81 | 76 |
exo, exosomes; MV, microvesicles; UC, ultracentrifugation.
∗,∗∗,∗∗∗Asterisks refer to which marker or isolation method is exceptionally used (in addition to the generally listed markers) in the corresponding reference.
Size was measured via transmission electron microscope, and/or nanoparticle tracking analysis, dynamic light scattering, or flow cytometry. Different differential centrifugation protocols were used: (1) 300g (5 minutes), 1200g (20 minutes), 10 000g (30 minutes), 100 000g (60 minutes); (2) 300g (5 minutes), 3000g (15 minutes), 10 000g (30 minutes), 100 000g (90 minutes); (3) 800g (30 min), 16 000g (45 min), 100 000g (2 hours); (4) 300g (10 minutes), 4000g (20 minutes), 100 000g (4 hours + 1 hours); (5) 300g (10 minutes), 2000g (20 minutes), 100 000g (30/70 minutes); (6) 450g (5 minutes), 16 000g (15 minutes), 120 000g (20 minutes); (7) 500g (5 minutes), 2000g (10 minutes), 10 000g (30 minutes), 100 000g (60 minutes); (8) 2000g (30 minutes), 20 000g (70 minutes), 170 000g (90 minutes); (9) 300g (10 minutes), 12 000g (45 minutes), 100 000g (90 minutes). Different centrifugation protocols were used: (10) 1500g (15 minutes), 20 000g (60 minutes); (11) 200g, (5 minutes), 1500g (30 minutes), 16 000g (60 minutes); (12) 500g (5 minutes), 2000g (10 minutes), 10 000g (30 minutes); (13) 800g (10 minutes), 2000g (10 minutes), 16 000g (30 minutes).